References

1. O vnesenii izmenenii v poryadok provedeniya profilakticheskogo meditsinskogo osmotra i dispanserizatsii opredelennykh grupp vzroslogo naseleniya, utverzhdennyi prikazom Ministerstva zdravookhraneniya Rossiiskoi Federatsii ot 27 aprelya 2021 g. № 404n: prikaz Ministerstva zdravookhraneniya Rossiiskoi Federatsii ot 19 iyulya 2024 g. № 378n [On Amendments to the Procedure for Preventive Medical Examination and Clinical Examination of Certain Groups of the Adult Population, Approved by the Order of the Ministry of Health of the Russian Federation of April 27, 2021 No 404n: Order of the Ministry of Health of the Russian Federation of July 19, 2024 No 378n]. Available at: https://base.garant.ru/409548505.
2. O napravlenii metodicheskikh rekomendatsii po dispanserizatsii muzhchin i zhenshchin reproduktivnogo vozrasta s tsel’yu otsenki reproduktivnogo zdorov’ya: pis’mo Ministerstva zdravookhraneniya Rossiiskoi Federatsii ot 8 aprelya 2024 g. № 17-6/I/2-6434 [On the Direction of Methodological Recommendations for Clinical Examination of Men and Women of Reproductive Age for the Purpose of Assessing Reproductive Health: Letter of the Ministry of Health of the Russian Federation dated April 8, 2024 No 17-6/I/2-6434]. Available at: https://docs.cntd.ru/document/1305669896.
3. Programme gosudarstvennykh garantii besplatnogo okazaniya grazhdanam meditsinskoi pomoshchi na 2025 god i na planovyi period 2026 i 2027 godov: postanovlenie Pravitel’stva Rossiiskoi Federatsii ot 27 dekabrya 2024 g. № 1940 [On the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2025 and for the Planning Period of 2026 and 2027: Decree of the Government of the Russian Federation of December 27, 2024 No 1940]. Available at: https://www.garant.ru/products/ipo/prime/doc/411138101.
4. Ob utverzhdenii Poryadka provedeniya profilakticheskogo meditsinskogo osmotra i dispanserizatsii opredelennykh grupp vzroslogo naseleniya: prikaz Ministerstva zdravookhraneniya Rossiiskoi Federatsii ot 27 aprelya 2021 g. № 404n (s izm. i dop.) [On Approval of the Procedure for Conducting a Preventive Medical Examination and Clinical Examination of Certain Groups of the Adult Population: Order of the Ministry of Health of the Russian Federation of April 27, 2021 No 404n (with amendments and addi-tions)]. Available at: https://ba¬se.ga¬rant.ru/¬401414440.
5. Rak molochnoi zhelezy: klinicheskie rekomendatsii [Breast Cancer: Clinical Guidelines]. Available at: https://cr.minzdrav.gov.ru/preview-cr/379_4.
6. Drapkina O.M., Kaprin A.D., Almazova I.I. et al. Skrining zlokachestvennykh novoobrazovanii molochnoi zhelezy v ramkakh dispanserizatsii opredelennykh grupp naseleniya. Metodicheskie rekomendatsii [Screening of malignant neoplasms of the mammary gland as part of the medical examination of certain population groups. Methodological recommendations]. Pervichnaya mediko-sanitarnaya pomoshch‘, 2024, vol. 1, no. 1, pp. 63–80. DOI: 10.15829/3034-4123-5.
7. Livzan M.A., Lyalyukova E.A., Petrosyan V.Yu., Chernysheva E.N. Skrining zlokachestvennykh novoobrazovanii: sostoyanie problemy v Rossii i mire [Screening of malig-nant neoplasms: the state of the problem in Russia and the world]. Eksperimental’naya i klinicheskaya gastroenterologiya, 2023, vol. 3(211), pp. 5–16.
8. Anderson B.O. Health system characteristics and breast cancer: Reduced mortality depends on health equity. Available at: https://www.uicc.org/blog/health-system-characteristics-and-breast-cancer-reduced-mortality-depends-health-equity.
9. Arnold M., Morgan E., Rumgay H. et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast., 2022, vol. 66, pp. 15–23. DOI: 10.1016/j.breast.2022.08.010.
10. Arzmi M.H., Majeed A.P.A., Musa R.M. et al. Deep learning in cancer diagnostics: a feature-based transfer learning evaluation.Singapore, Springer, 2023, 44 p.
11. Breast cancer burden in EU-27. Available at: https://ecis.jrc.ec.europa.eu/sites/default/files/2023-12/Breast_cancer_en-Dec_2020.pdf.
12. Cancer statistics – specific cancers. Available at: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Cancer_statistics_-_specific_cancers.
13. Chow R.D., Bradley E.H., Gross C.P. Comparison of cancer-related spending and mortality rates in the US vs 21 high-income countries. JAMA Health Forum,2022, vol. 3, no. 5, pp. e221229-e221229.
14. Ciuba A., Wnuk K., Nitsch-Osuch A., Kulpa M. Health Care Accessibility and Breast Cancer Mortality in Europe. Int J Environ Res Public Health, 2022, vol. 19(20), 13605. DOI: 10.3390/ijerph192013605.
15. Dafni U, Tsourti Z, Alatsathianos I. Breast Cancer Statistics in the European Union: Incidence and Survival across European Countries. Breast Care (Basel), 2019, vol. 14(6), pp. 344-353. DOI: 10.1159/000503219.
16. Giaquinto A.N., Sung H., Newman L.A. et al. Breast cancer statistics 2024. CA Cancer J Clin., 2024, vol. 74(6), pp. 477–495. DOI: 10.3322/caac.21863.
17. Lauby-Secretan B., Scoccianti C., Loomis D. et al. Breast-cancer screening – viewpoint of the IARC Working Group. New England journal of medicine, 2015, vol. 372(24), pp. 2353–2358.
18. Liu H., Zhan H., Sun D., Zhang Y. Comparison of BSGI, MRI, mammography, and ultrasound for the diagnosis of breast lesions and their correlations with specific molecular subtypes in Chinese women. BMC Med Imaging, 2020, vol. 20(1), 98. DOI: 10.1186/s12880-020-00497-w.
19. Łukasiewicz S., Czeczelewski M., Forma A. et al. Breast Cancer-Epidemiology, Risk Factors, Classification, Prognostic Markers, and Current Treatment Strategies-An Updated Review. Cancers (Basel), 2021, vol. 13(17), 4287. DOI: 10.3390/cancers13174287.
20. McKee M. Reducing hospital beds: what are the lessons to be learned? Available at: https://iris.who.int/bitstream/handle/10665/107615/WHO-EURO-2004-654-40389-54118-eng.pdf?sequence=8&isAllowed=y.
21. Oeffinger K.C., Fontham E.T., Etzioni R. et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. Jama, 2015, vol.314(15), pp. 1599–1614.
22. Pereira R.O., Luz L.A.D., Chagas D.C. et al. Evaluation of the accuracy of mammography, ultrasound and magnetic resonance imaging in suspect breast lesions. Clinics (Sao Paulo), 2020, vol. 75, e1805. DOI: 10.6061/clinics/2020/e1805.
23. Predictions of the future cancer incidence and mortality burden worldwide up until 2050. Available at: https://gco.iarc.fr/today/online-analysis-pie.
24. Tagliafico A.S., Calabrese M., Mariscotti G. et al. Adjunct Screening With Tomosynthesis or Ultrasound in Women With Mammography-Negative Dense Breasts: Interim Report of a Prospective Comparative Trial. J Clin Oncol., 2016, vol. 34(16), pp. 1882–1888. DOI: 10.1200/JCO.2015.63.4147.